This article examines viral and non-viral vectors in gene therapy, highlighting their mechanisms, advantages, and limitations ...

A study on bat genomes, involving Texas Tech University, discovered genetic adaptations that help bats resist viral ...

The SARS-CoV-2 pandemic interrupted much respiratory research. Respiratory clinical academics joined colleagues in providing clinical care, and global research efforts were directed to finding new ...

The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or ...

Five years removed from the COVID-19 outbreak, scientists around the world are still studying its effects and, more importantly, ways those effects can be mitigated in the future.

It's an unusual winter for respiratory illnesses. The flu is peaking twice: once in early January and again in February.

The study revealed that a gene common in some bats can reduce the production of the SARS-CoV-2 virus by up to 90%, which could help lead to new medical approaches to combating viral diseases.

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Findings indicate a sharp drop in immunity after Omicron infection, stressing the necessity for updated vaccines to enhance ...